Skip to main content
Top
Published in: Endocrine 2/2010

01-10-2010 | Original Article

Increased ghrelin sensitivity and calorie consumption in subordinate monkeys is affected by short-term astressin B administration

Authors: Vasiliki Michopoulos, Tammy Loucks, Sarah L. Berga, Jean Rivier, Mark E. Wilson

Published in: Endocrine | Issue 2/2010

Login to get access

Abstract

Animals chronically exposed to stressors with access to diets high in fat and sugar consume and prefer these diets, a result consistent with the association between stress and comfort food ingestion in humans. As social subordination in rhesus monkeys provides an ethologically relevant translational model of psychosocial stress, we tested the hypothesis that differences in food intake between dominant and subordinate female monkeys are due to corticotropin-releasing hormone-(CRH) induced alteration in sensitivity to ghrelin, a potent orexigenic signal. We assessed food intake of animals given a choice between a low (LCD) and high calorie diet (HCD) in response to 4-day treatment with the CRH receptor antagonist, astressin B, and to an acute treatment of ghrelin. Ghrelin stimulated intake of LCD in subordinates but did not further increase consumption of HCD, whereas ghrelin decreased LCD consumption without affecting HCD intake in dominant females. Astressin B decreased cortisol levels and increased preference for and intake of the HCD in subordinates and decreased calorie intake and HCD preference in dominant animals. These results suggest that increased caloric intake by subordinates may, in part, be explained by a greater sensitivity to postprandial increases in ghrelin and that CRH receptor antagonism leading to a decrease in cortisol has mixed effects on food choice depending on an individual’s stress background.
Literature
2.
go back to reference A. Bartolomucci, T. Pederzani, P. Sacerdote, A.E. Panerai, S. Parmigiani, P. Palanza, Psychoneuroendocrinology 29, 899–910 (2004)CrossRefPubMed A. Bartolomucci, T. Pederzani, P. Sacerdote, A.E. Panerai, S. Parmigiani, P. Palanza, Psychoneuroendocrinology 29, 899–910 (2004)CrossRefPubMed
3.
go back to reference H. Jarrell, J.B. Hoffman, J.R. Kaplan, S. Berga, B. Kinkead, M.E. Wilson, Physiol. Behav. 93, 807–819 (2008)CrossRefPubMed H. Jarrell, J.B. Hoffman, J.R. Kaplan, S. Berga, B. Kinkead, M.E. Wilson, Physiol. Behav. 93, 807–819 (2008)CrossRefPubMed
6.
9.
go back to reference M.F. Dallman, N. Pecoraro, S.F. Akana, S.E. La Fleur, F. Gomez, H. Houshyar, M.E. Bell, S. Bhatnagar, K.D. Laugero, S. Manalo, Proc. Natl Acad. Sci. USA 100, 11696–11701 (2003)CrossRefPubMed M.F. Dallman, N. Pecoraro, S.F. Akana, S.E. La Fleur, F. Gomez, H. Houshyar, M.E. Bell, S. Bhatnagar, K.D. Laugero, S. Manalo, Proc. Natl Acad. Sci. USA 100, 11696–11701 (2003)CrossRefPubMed
10.
go back to reference G.N. Smagin, L.A. Howell, S. Redmann Jr., D.H. Ryan, R.B. Harris, Am. J. Physiol. 276, R1461–R1468 (1999)PubMed G.N. Smagin, L.A. Howell, S. Redmann Jr., D.H. Ryan, R.B. Harris, Am. J. Physiol. 276, R1461–R1468 (1999)PubMed
13.
go back to reference M.J. Kas, A.W. Bruijnzeel, J.R. Haanstra, V.M. Wiegant, R.A. Adan, J. Mol. Endocrinol. 35, 159–164 (2005)CrossRefPubMed M.J. Kas, A.W. Bruijnzeel, J.R. Haanstra, V.M. Wiegant, R.A. Adan, J. Mol. Endocrinol. 35, 159–164 (2005)CrossRefPubMed
14.
go back to reference L.E. Kuo, J.B. Kitlinska, J.U. Tilan, L. Li, S.B. Baker, M.D. Johnson, E.W. Lee, M.S. Burnett, S.T. Fricke, R. Kvetnansky, H. Herzog, Z. Zukowska, Nat. Med. 13, 803 (2007) L.E. Kuo, J.B. Kitlinska, J.U. Tilan, L. Li, S.B. Baker, M.D. Johnson, E.W. Lee, M.S. Burnett, S.T. Fricke, R. Kvetnansky, H. Herzog, Z. Zukowska, Nat. Med. 13, 803 (2007)
16.
go back to reference A. Stengel, M. Goebel, M. Million, M.P. Stenzel-Poore, P. Kobelt, H. Monnikes, Y. Tache, L. Wang, Endocrinology 150, 153–160 (2009)CrossRefPubMed A. Stengel, M. Goebel, M. Million, M.P. Stenzel-Poore, P. Kobelt, H. Monnikes, Y. Tache, L. Wang, Endocrinology 150, 153–160 (2009)CrossRefPubMed
17.
21.
22.
go back to reference C.A. Shively, K.A. Grant, R.L. Ehrenkaufer, R.H. Mach, M.A. Nader, Ann. N. Y. Acad. Sci. 807, 574–577 (1997)CrossRefPubMed C.A. Shively, K.A. Grant, R.L. Ehrenkaufer, R.H. Mach, M.A. Nader, Ann. N. Y. Acad. Sci. 807, 574–577 (1997)CrossRefPubMed
23.
go back to reference M.E. Wilson, J. Fisher, A. Fischer, V. Lee, R.B. Harris, T.J. Bartness, Physiol. Behav. 94, 586–594 (2008)CrossRefPubMed M.E. Wilson, J. Fisher, A. Fischer, V. Lee, R.B. Harris, T.J. Bartness, Physiol. Behav. 94, 586–594 (2008)CrossRefPubMed
25.
go back to reference M.E.Wilson, K. Pazol, A. Legendre, J. Fisher, K. Chikazawa, Endocrine 26, 89 (2005) M.E.Wilson, K. Pazol, A. Legendre, J. Fisher, K. Chikazawa, Endocrine 26, 89 (2005)
26.
go back to reference M. Paiardini, J. Hoffman, B. Cervasi, A.M. Ortiz, F. Stroud, G. Silvestri, M.E. Wilson, Brain Behav. Immun. 23, 286–293 (2009)CrossRefPubMed M. Paiardini, J. Hoffman, B. Cervasi, A.M. Ortiz, F. Stroud, G. Silvestri, M.E. Wilson, Brain Behav. Immun. 23, 286–293 (2009)CrossRefPubMed
29.
go back to reference J.R. Kaplan, M.R. Adams, T.B. Clarkson, S.B. Manuck, C.A. Shively, J.K. Williams, Psychosom. Med. 58, 598–611 (1996)PubMed J.R. Kaplan, M.R. Adams, T.B. Clarkson, S.B. Manuck, C.A. Shively, J.K. Williams, Psychosom. Med. 58, 598–611 (1996)PubMed
30.
go back to reference D. Morgan, K.A. Grant, H.D. Gage, R.H. Mach, J.R. Kaplan, O. Prioleau, S.H. Nader, N. Buchheimer, R.L. Ehrenkaufer, M.A. Nader, Nat. Neurosci. 5, 169–174 (2002)CrossRefPubMed D. Morgan, K.A. Grant, H.D. Gage, R.H. Mach, J.R. Kaplan, O. Prioleau, S.H. Nader, N. Buchheimer, R.L. Ehrenkaufer, M.A. Nader, Nat. Neurosci. 5, 169–174 (2002)CrossRefPubMed
31.
go back to reference K.A. Grant, C.A. Shively, M.A. Nader, R.L. Ehrenkaufer, S.W. Line, T.E. Morton, H.D. Gage, R.H. Mach, Synapse 29, 80–83 (1998)CrossRefPubMed K.A. Grant, C.A. Shively, M.A. Nader, R.L. Ehrenkaufer, S.W. Line, T.E. Morton, H.D. Gage, R.H. Mach, Synapse 29, 80–83 (1998)CrossRefPubMed
32.
go back to reference C.A. Shively, D.P. Friedman, H.D. Gage, M.C. Bounds, C. Brown-Proctor, J.B. Blair, J.A. Henderson, M.A. Smith, N. Buchheimer, Arch. Gen. Psychiatry 63, 396–403 (2006)CrossRefPubMed C.A. Shively, D.P. Friedman, H.D. Gage, M.C. Bounds, C. Brown-Proctor, J.B. Blair, J.A. Henderson, M.A. Smith, N. Buchheimer, Arch. Gen. Psychiatry 63, 396–403 (2006)CrossRefPubMed
33.
34.
go back to reference D.A. Gust, T.P. Gordon, M.E. Wilson, A. Ahmed-Ansari, A.R. Brodie, H.M. McClure, Brain Behav. Immun. 5, 296–307 (1991)CrossRefPubMed D.A. Gust, T.P. Gordon, M.E. Wilson, A. Ahmed-Ansari, A.R. Brodie, H.M. McClure, Brain Behav. Immun. 5, 296–307 (1991)CrossRefPubMed
35.
go back to reference C.A. Shively, T.C. Register, D.P. Friedman, T.M. Morgan, J. Thompson, T. Lanier, Biol. Psychol. 69, 67–84 (2005)CrossRefPubMed C.A. Shively, T.C. Register, D.P. Friedman, T.M. Morgan, J. Thompson, T. Lanier, Biol. Psychol. 69, 67–84 (2005)CrossRefPubMed
37.
go back to reference J.H. Broadbear, G. Winger, J.E. Rivier, K.C. Rice, J.H. Woods, Neuropsychopharmacology 29, 1112–1121 (2004)CrossRefPubMed J.H. Broadbear, G. Winger, J.E. Rivier, K.C. Rice, J.H. Woods, Neuropsychopharmacology 29, 1112–1121 (2004)CrossRefPubMed
38.
40.
go back to reference M.L. Walker, T.P. Gordon, M.E. Wilson, J. Med. Primatol. 11, 291–302 (1982)PubMed M.L. Walker, T.P. Gordon, M.E. Wilson, J. Med. Primatol. 11, 291–302 (1982)PubMed
41.
go back to reference M.S. Blank, T.P. Gordon, M.E. Wilson, Acta Endocrinol. (Copenh) 102, 190–195 (1983) M.S. Blank, T.P. Gordon, M.E. Wilson, Acta Endocrinol. (Copenh) 102, 190–195 (1983)
42.
go back to reference D.C. Choi, A.R. Furay, N.K. Evanson, Y.M. Ulrich-Lai, M.M. Nguyen, M.M. Ostrander, J.P. Herman, Psychoneuroendocrinology 33, 659–669 (2008)CrossRefPubMed D.C. Choi, A.R. Furay, N.K. Evanson, Y.M. Ulrich-Lai, M.M. Nguyen, M.M. Ostrander, J.P. Herman, Psychoneuroendocrinology 33, 659–669 (2008)CrossRefPubMed
43.
go back to reference H. Kim, W.W. Whang, H.T. Kim, K.H. Pyun, S.Y. Cho, D.H. Hahm, H.J. Lee, I. Shim, Brain Res. 983, 201–208 (2003)CrossRefPubMed H. Kim, W.W. Whang, H.T. Kim, K.H. Pyun, S.Y. Cho, D.H. Hahm, H.J. Lee, I. Shim, Brain Res. 983, 201–208 (2003)CrossRefPubMed
45.
go back to reference T.H. Heiskanen, L.K. Niskanen, J.J. Hintikka, H.T. Koivumaa-Honkanen, K.M. Honkalampi, K.M. Haatainen, H.T. Viinamaki, J. Clin. Psychiatry 67, 1422–1427 (2006)CrossRefPubMed T.H. Heiskanen, L.K. Niskanen, J.J. Hintikka, H.T. Koivumaa-Honkanen, K.M. Honkalampi, K.M. Haatainen, H.T. Viinamaki, J. Clin. Psychiatry 67, 1422–1427 (2006)CrossRefPubMed
46.
go back to reference D.A. Zellner, S. Loaiza, Z. Gonzalez, J. Pita, J. Morales, D. Pecora, A. Wolf, Physiol. Behav. 87, 789–793 (2006)CrossRefPubMed D.A. Zellner, S. Loaiza, Z. Gonzalez, J. Pita, J. Morales, D. Pecora, A. Wolf, Physiol. Behav. 87, 789–793 (2006)CrossRefPubMed
47.
go back to reference N. Nagaya, M. Kojima, M. Uematsu, M. Yamagishi, H. Hosoda, H. Oya, Y. Hayashi, K. Kangawa, Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R1483–R1487 (2001)PubMed N. Nagaya, M. Kojima, M. Uematsu, M. Yamagishi, H. Hosoda, H. Oya, Y. Hayashi, K. Kangawa, Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R1483–R1487 (2001)PubMed
48.
go back to reference N.M. Neary, C.J. Small, A.M. Wren, J.L. Lee, M.R. Druce, C. Palmieri, G.S. Frost, M.A. Ghatei, R.C. Coombes, S.R. Bloom, J. Clin. Endocrinol. Metab. 89, 2832–2836 (2004)CrossRefPubMed N.M. Neary, C.J. Small, A.M. Wren, J.L. Lee, M.R. Druce, C. Palmieri, G.S. Frost, M.A. Ghatei, R.C. Coombes, S.R. Bloom, J. Clin. Endocrinol. Metab. 89, 2832–2836 (2004)CrossRefPubMed
49.
go back to reference T. Akamizu, K. Takaya, T. Irako, H. Hosoda, S. Teramukai, A. Matsuyama, H. Tada, K. Miura, A. Shimizu, M. Fukushima, M. Yokode, K. Tanaka, K. Kangawa, Eur. J. Endocrinol. 150, 447–455 (2004)CrossRefPubMed T. Akamizu, K. Takaya, T. Irako, H. Hosoda, S. Teramukai, A. Matsuyama, H. Tada, K. Miura, A. Shimizu, M. Fukushima, M. Yokode, K. Tanaka, K. Kangawa, Eur. J. Endocrinol. 150, 447–455 (2004)CrossRefPubMed
50.
go back to reference M.R. Druce, A.M. Wren, A.J. Park, J.E. Milton, M. Patterson, G. Frost, M.A. Ghatei, C. Small, S.R. Bloom, Int. J. Obes. (Lond) 29, 1130–1136 (2005)CrossRef M.R. Druce, A.M. Wren, A.J. Park, J.E. Milton, M. Patterson, G. Frost, M.A. Ghatei, C. Small, S.R. Bloom, Int. J. Obes. (Lond) 29, 1130–1136 (2005)CrossRef
51.
go back to reference J. Kamegai, H. Tamura, T. Shimizu, S. Ishii, H. Sugihara, I. Wakabayashi, Endocrinology 141, 4797–4800 (2000)CrossRefPubMed J. Kamegai, H. Tamura, T. Shimizu, S. Ishii, H. Sugihara, I. Wakabayashi, Endocrinology 141, 4797–4800 (2000)CrossRefPubMed
52.
go back to reference A.M. Wren, C.J. Small, H.L. Ward, K.G. Murphy, C.L. Dakin, S. Taheri, A.R. Kennedy, G.H. Roberts, D.G. Morgan, M.A. Ghatei, S.R. Bloom, Endocrinology 141, 4325–4328 (2000)CrossRefPubMed A.M. Wren, C.J. Small, H.L. Ward, K.G. Murphy, C.L. Dakin, S. Taheri, A.R. Kennedy, G.H. Roberts, D.G. Morgan, M.A. Ghatei, S.R. Bloom, Endocrinology 141, 4325–4328 (2000)CrossRefPubMed
53.
go back to reference T. Shimbara, M.S. Mondal, T. Kawagoe, K. Toshinai, S. Koda, H. Yamaguchi, Y. Date, M. Nakazato, Neurosci. Lett. 369, 75–79 (2004)CrossRefPubMed T. Shimbara, M.S. Mondal, T. Kawagoe, K. Toshinai, S. Koda, H. Yamaguchi, Y. Date, M. Nakazato, Neurosci. Lett. 369, 75–79 (2004)CrossRefPubMed
54.
go back to reference A. Abizaid, Z.W. Liu, Z.B. Andrews, M. Shanabrough, E. Borok, J.D. Elsworth, R.H. Roth, M.W. Sleeman, M.R. Picciotto, M.H. Tschop, X.B. Gao, T.L. Horvath, J. Clin. Invest. 116, 3229–3239 (2006)CrossRefPubMed A. Abizaid, Z.W. Liu, Z.B. Andrews, M. Shanabrough, E. Borok, J.D. Elsworth, R.H. Roth, M.W. Sleeman, M.R. Picciotto, M.H. Tschop, X.B. Gao, T.L. Horvath, J. Clin. Invest. 116, 3229–3239 (2006)CrossRefPubMed
56.
57.
66.
go back to reference B. Knutson, S. Cole, O. Wolkowitz, V. Reus, T. Chan, E. Moore, Ann. N. Y. Acad. Sci. 807, 492–493 (1997)CrossRefPubMed B. Knutson, S. Cole, O. Wolkowitz, V. Reus, T. Chan, E. Moore, Ann. N. Y. Acad. Sci. 807, 492–493 (1997)CrossRefPubMed
67.
go back to reference P.T. Mehlman, J.D. Higley, I. Faucher, A.A. Lilly, D.M. Taub, J. Vickers, S.J. Suomi, M. Linnoila, Am. J. Psychiatry 152, 907–913 (1995)PubMed P.T. Mehlman, J.D. Higley, I. Faucher, A.A. Lilly, D.M. Taub, J. Vickers, S.J. Suomi, M. Linnoila, Am. J. Psychiatry 152, 907–913 (1995)PubMed
71.
go back to reference S.L. Berga, J.F. Mortola, L. Girton, B. Suh, G. Laughlin, P. Pham, S.S. Yen, J. Clin. Endocrinol. Metab. 68, 301–308 (1989)CrossRefPubMed S.L. Berga, J.F. Mortola, L. Girton, B. Suh, G. Laughlin, P. Pham, S.S. Yen, J. Clin. Endocrinol. Metab. 68, 301–308 (1989)CrossRefPubMed
Metadata
Title
Increased ghrelin sensitivity and calorie consumption in subordinate monkeys is affected by short-term astressin B administration
Authors
Vasiliki Michopoulos
Tammy Loucks
Sarah L. Berga
Jean Rivier
Mark E. Wilson
Publication date
01-10-2010
Publisher
Springer US
Published in
Endocrine / Issue 2/2010
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-010-9378-5

Other articles of this Issue 2/2010

Endocrine 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine